Polymers for improving the in vivo transduction efficiency of AAV2 vectors.
<h4>Background</h4>Adeno-associated virus has attracted great attention as vehicle for body-wide gene delivery. However, for the successful treatment of a disease such as Duchenne muscular dystrophy infusion of very large amounts of vectors is required. This not only raises questions abo...
Guardado en:
Autores principales: | Gilles Moulay, Sylvie Boutin, Carole Masurier, Daniel Scherman, Antoine Kichler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1de877734aa451f83ba586ae2ea074a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AAV vector-mediated in vivo reprogramming into pluripotency
por: Elena Senís, et al.
Publicado: (2018) -
Standard screening methods underreport AAV-mediated transduction and gene editing
por: Jonathan F. Lang, et al.
Publicado: (2019) -
Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.
por: Séverine Ciré, et al.
Publicado: (2014) -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Marie-Laure Arotcarena, et al.
Publicado: (2021) -
Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy
por: Ruth Jinfen Chai, et al.
Publicado: (2021)